| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A call for Essays: stories from the frontline during the COVID-19 pandemic
|
Woolven, Sophie
|
|
|
8 |
11 |
p. 1074
|
article
|
| 2 |
Amazon fires coincide with increased respiratory illnesses in indigenous populations
|
Alves, Lise
|
|
|
8 |
11 |
p. e84
|
article
|
| 3 |
Asthma in children during the COVID-19 pandemic: lessons from lockdown and future directions for management
|
Gupta, Atul
|
|
|
8 |
11 |
p. 1070-1071
|
article
|
| 4 |
Can perturbations in microbial maturation cause asthma?
|
Stokholm, Jakob
|
|
|
8 |
11 |
p. 1063-1065
|
article
|
| 5 |
Correction to Lancet Respir Med 2020; 8: 1154–58
|
|
|
|
8 |
11 |
p. e78
|
article
|
| 6 |
Correction to Lancet Respir Med 2020; 8: 786–94
|
|
|
|
8 |
11 |
p. e78
|
article
|
| 7 |
COVID-19 recovery: potential treatments for post-intensive care syndrome
|
Bangash, Mansoor N
|
|
|
8 |
11 |
p. 1071-1073
|
article
|
| 8 |
COVID-19 testing in the UK
|
The Lancet Respiratory Medicine,
|
|
|
8 |
11 |
p. 1061
|
article
|
| 9 |
COVID-19 vaccine trials in Africa
|
Makoni, Munyaradzi
|
|
|
8 |
11 |
p. e79-e80
|
article
|
| 10 |
Decreasing antibiotic use, the gut microbiota, and asthma incidence in children: evidence from population-based and prospective cohort studies
|
Patrick, David M
|
|
|
8 |
11 |
p. 1094-1105
|
article
|
| 11 |
Discovery of lung cancer after an injury on holiday
|
Kirby, Tony
|
|
|
8 |
11 |
p. 1075
|
article
|
| 12 |
ECMO for severe ARDS associated with COVID-19: now we know we can, but should we?
|
Shekar, Kiran
|
|
|
8 |
11 |
p. 1066-1068
|
article
|
| 13 |
2020 European Respiratory Society International Virtual Congress
|
Venkatesan, Priya
|
|
|
8 |
11 |
p. e82-e83
|
article
|
| 14 |
Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study
|
Schmidt, Matthieu
|
|
|
8 |
11 |
p. 1121-1131
|
article
|
| 15 |
Human recombinant soluble ACE2 in severe COVID-19
|
Zoufaly, Alexander
|
|
|
8 |
11 |
p. 1154-1158
|
article
|
| 16 |
Imaging research in fibrotic lung disease; applying deep learning to unsolved problems
|
Walsh, Simon L F
|
|
|
8 |
11 |
p. 1144-1153
|
article
|
| 17 |
Inhaled corticosteroids and COVID-19-related mortality: confounding or clarifying?
|
Singh, Dave
|
|
|
8 |
11 |
p. 1065-1066
|
article
|
| 18 |
Pharmacotherapy for pulmonary arterial hypertension
|
Burki, Talha Khan
|
|
|
8 |
11 |
p. e81
|
article
|
| 19 |
Pooled saliva samples for COVID-19 surveillance programme
|
Fogarty, Andrew
|
|
|
8 |
11 |
p. 1078-1080
|
article
|
| 20 |
Prevalence and risk factors of small airway dysfunction, and association with smoking, in China: findings from a national cross-sectional study
|
Xiao, Dan
|
|
|
8 |
11 |
p. 1081-1093
|
article
|
| 21 |
Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform
|
Schultze, Anna
|
|
|
8 |
11 |
p. 1106-1120
|
article
|
| 22 |
Small airway dysfunction: not so silent after all?
|
Papi, Alberto
|
|
|
8 |
11 |
p. 1062-1063
|
article
|
| 23 |
Targeting MET amplification in EGFR-mutant non-small-cell lung cancer
|
Rosell, Rafael
|
|
|
8 |
11 |
p. 1068-1070
|
article
|
| 24 |
Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial
|
Wu, Yi-Long
|
|
|
8 |
11 |
p. 1132-1143
|
article
|
| 25 |
The Russian vaccine for COVID-19
|
Burki, Talha Khan
|
|
|
8 |
11 |
p. e85-e86
|
article
|
| 26 |
The UCL Ventura CPAP device for COVID-19
|
Singer, Mervyn
|
|
|
8 |
11 |
p. 1076-1078
|
article
|
Journal description